Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 903
Guide Official Revision Description Reason for Update
Version Date Number Of Change
will accept a level III HST. If
the HST is positive for OSA,
no further testing is
necessary and treatment in
accordance with the AASI
must be followed. However,
if the HST is equivocal, a
higher level test such as an
in-lab sleep study will be
needed unless a sleep
medicine specialist
determines no further study
is necessary and documents
the rationale.”
2015 04/29/2015 4. Medical Policy In Disease Protocols,
Protocol for History of
Diabetes Mellitus Type II
Medication – Controlled (Non
Insulin), Protocol for
Metabolic Syndrome, and
CACI – Pre Diabetes, revise
to add 14 day wait period for
use of Metformin only. (Any
other single diabetes
medication requires a 60-day
wait period.)
2015 04/29/2015 5. Medical Policy In Item 43. Spine and other
Musculoskeletal, add a
disposition table for Gout
and Pseudogout.
2015 04/21/2015 1. Medical Policy In Disease Protocols,
Protocol for Diabetes
Mellitus, Type I and Type II –
Insulin Treated, revise to
remove reference to class of
certification.
2015 04/21/2015 2. Medical Policy In Pharmaceuticals
(Therapeutic Medications)
Diabetes Mellitus – Insulin
Treated, revise language
under III. Aeromedical
Decision Considerations.
Remove reference to class
of certification.
2015 04/16/2015 1. Medical Policy In Disease Protocols,
Protocol for History Diabetes
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
